drugset / Trial / NCT03241030

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial

NCT03241030

Phase 2 Completed 102 enrolled University of Texas at Austin
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to see if sucralfate, a medication commonly used for patients with stomach ulcers, may help pediatric patients with mouth ulcers decrease their pain level and improve their ability to drink.

Timeline

Start
2017-09-12
Primary completion
2018-07-31
Completion
2019-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Sucralfate Unknown 20 mg/kg
Background Acetaminophen Small molecule 15 mg/kg
Background Ibuprofen Small molecule 10 mg/kg